The Pharmacy Benefit Brief | May 2021

  Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers.     It’s a Dog Eat Dog World… As a state legislator or regulator in the health care arena, you understand the importance of competition...

Keep Reading

Rebate Rule Effective Date Postponed to 2023

(Washington, D.C.) — In response to litigation brought by the Pharmaceutical Care Management Association (PCMA) challenging the Medicare Part D rebate rule, the Biden Administration agreed to postpone the effective date of the provisions of the rule relating to the elimination of the regulatory discount safe harbor for retrospective rebates, from January 1, 2022, to January...

Keep Reading

RealClear Policy: Abolishing Drug Rebates Will Raise Costs for Seniors and Taxpayers

President Trump needs a win on health care, and prescription drug costs are in the crosshairs. He issued an executive order to eliminate drug rebates paid to Medicare Part D plans, claiming that this would save seniors billions of dollars. To ensure that costs won’t pop up elsewhere, the order directs Health and Human Services (HHS) Secretary...

Keep Reading

PCMA Offers Policy Solutions to Reduce Prescription Drug Costs

(Washington, D.C.) — As Congress begins to examine high prescription drug prices, the Pharmaceutical Care Management Association (PCMA) sent letters to several congressional committees highlighting the value pharmacy benefit managers (PBMs) provide to patients and payers as well as outlining policy options to reduce prescription drug costs. PBMs administer prescription drug plans for more than...

Keep Reading

Home Delivery of Drugs

Keep Reading

NCPA Report Shows Drugstore Lobby Agenda Raises Rx Costs for Small Businesses, Government Programs

National Center for Policy Analysis Warns Policymakers of Costly, Unintended Consequences Federal and state policymakers should avoid enacting laws that undermine payers’ ability to use mail-service pharmacies, preferred pharmacy networks, and other innovative pharmacy benefit management (PBM) tools, the National Center for Policy Analysis (NCPA) asserts in a new report, “Unnecessary Regulations that Increase Prescription...

Keep Reading

PCMA: CMS Analysis Shows Mail-Service Pharmacies More Affordable Than Drugstores

  A new Centers for Medicare & Medicaid Services (CMS) analysis comparing mail-service pharmacies and retail pharmacies in Medicare Part D (“Part D Claims Analysis: Negotiated Pricing Between General Mail Order and Retail Pharmacies”), finds that mail-service pharmacies have lower overall costs, the Pharmaceutical Care Management Association (PCMA) said today. In its analysis, CMS identified...

Keep Reading

PCMA: NCPA Report Shows Drugstore Lobby Agenda Raises Rx Costs for Small Businesses, Government Programs

  (Washington, DC)—Federal and state policymakers should avoid enacting laws that undermine payers’ ability to use mail-service pharmacies, preferred pharmacy networks, and other innovative pharmacy benefit management (PBM) tools, the National Center for Policy Analysis (NCPA) asserts in a new report, “Unnecessary Regulations that Increase Prescription Drug Costs.” “This report shows policymakers that appeasing the...

Keep Reading

Report: Anti-PBM Laws Could Raise Health Care Costs for Oklahoma Businesses, Consumers, Government Programs

  (Washington, DC)— Oklahoma policymakers should avoid enacting laws that undermine payers’ ability to use mail-service pharmacies, preferred pharmacy networks, and other innovative pharmacy benefit management (PBM) tools, the National Center for Policy Analysis (NCPA) asserts in a new white paper, “Unnecessary Regulations that Increase Prescription Drug Costs.” NCPA is a nonprofit, nonpartisan public policy...

Keep Reading

Independent Drugstore Lobby Seeks ‘License to Collude’: Proposal Would Increase Costs, Decrease Competition

(Washington, DC) — While its own economic report found that 400 new independent drugstores opened last year and that profits (3.2%) were three times greater than the rate of U.S. inflation (1.1%) during an economic downturn, the independent drugstore lobby continues to seek unprecedented collective bargaining rights in order to charge consumers higher prices on...

Keep Reading